S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.
Pharmacogenetics
; 6(6): 521-6, 1996 Dec.
Article
en En
| MEDLINE
| ID: mdl-9014201
The polymorphic metabolism of S-mephenytoin and the distribution of two known deleterious mutant CYP2C19 alleles was determined among 114 healthy unrelated black Ethiopians. Six subjects (5.2%) were poor metabolizers (PMs) of S-mephenytoin. The frequencies of the defective CYP2C19*2 (CYP2C19m1) and CYP2C19*3 (CYP2C19m2) alleles were 0.14 and 0.02, respectively. Three of the PMs were homozygous for the CYP2C19*2 allele and the remaining three PMs were heterozygous for both the CYP2C19*2 and CYP2C19*3 mutant alleles. It is concluded that the frequency of PMs for S-mephenytoin is similar in Ethiopians, Zimbabweans and Caucasians and that the CYP2C19*3 allele, for the first time identified in a black population, together with the CYP2C19*2 allele account for all of the defective CYP2C19 alleles among the Ethiopian PMs.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Polimorfismo Genético
/
Hidrocarburo de Aril Hidroxilasas
/
Sistema Enzimático del Citocromo P-450
/
Oxigenasas de Función Mixta
/
Mefenitoína
Límite:
Female
/
Humans
/
Male
País/Región como asunto:
Africa
Idioma:
En
Revista:
Pharmacogenetics
Año:
1996
Tipo del documento:
Article
País de afiliación:
Etiopia
Pais de publicación:
Reino Unido